Skip to main content
All lobbying filings

PATIENTSACT

Lobbying for PATIENTSACT · Educate & advocate for patients' safety rights and freedom of choice in treatment options

 Filing 2nd Quarter - Termination
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 8, 2026
Expenses
$120,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Illinois
Representation ended
May 28, 2026
The registrant reported terminating its work for this client.

Official filing document

 Lobbying activity 2
Medicare/Medicaid

Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.

Medical/Disease Research/Clinical Labs

Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem